Tongda Xu Selected Research

Enalapril

1/2019

Effects of the Angiotensin-Receptor Neprilysin Inhibitor on Cardiac Reverse Remodeling: Meta-Analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tongda Xu Research Topics

Disease

11	Ischemia 01/2021 - 11/2011
9	Heart Failure 01/2024 - 01/2016
8	Reperfusion Injury 01/2023 - 11/2011
8	Myocardial Infarction 01/2022 - 06/2013
7	Myocardial Ischemia (Ischemic Heart Diseases) 01/2023 - 01/2016
3	ST Elevation Myocardial Infarction 11/2023 - 01/2022
3	Infarction (Infarctions) 01/2021 - 01/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 12/2012
2	Atherosclerosis 11/2023 - 01/2014
2	Insulin Resistance 01/2023 - 01/2016
2	Hypertension (High Blood Pressure) 01/2023 - 01/2023
2	Diabetes Mellitus 01/2023 - 12/2012
2	Non-ST Elevated Myocardial Infarction 01/2022 - 01/2022
2	Inflammation (Inflammations) 10/2021 - 01/2014
2	Wounds and Injuries (Trauma) 01/2020 - 01/2015
1	Respiratory Insufficiency (Respiratory Failure) 01/2023
1	Prediabetic State (Prediabetes) 01/2023
1	Coronary Disease (Coronary Heart Disease) 01/2022
1	Ventricular Remodeling 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Infections 01/2022
1	COVID-19 10/2021
1	Gliosis 01/2021
1	Brain Injuries (Brain Injury) 01/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Hemorrhage 11/2020
1	Acute Coronary Syndrome 11/2020
1	Neoplasms (Cancer) 03/2019
1	Hypertrophy 01/2019
1	Hypoxia (Hypoxemia) 01/2016
1	Fibrosis (Cirrhosis) 01/2015

Drug/Important Bio-Agent (IBA)

11	LuteolinIBA 01/2023 - 12/2012
5	Dobutamine FDA LinkGeneric 01/2023 - 06/2013
4	Sarcoplasmic Reticulum Calcium-Transporting ATPasesIBA 01/2024 - 01/2013
4	salvianolic acid AIBA 03/2019 - 11/2011
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2016 - 01/2013
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2023
3	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2022
3	Angiotensin Receptors (Angiotensin II Receptor)IBA 06/2021 - 01/2019
3	Neprilysin (Neutral Endopeptidase)IBA 06/2021 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 01/2018
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2024 - 01/2020
2	FlavonoidsIBA 11/2023 - 01/2013
2	Indicators and Reagents (Reagents)IBA 01/2023 - 01/2023
2	AlbuminsIBA 01/2023 - 01/2023
2	Long Noncoding RNAIBA 01/2023 - 01/2023
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 01/2019
2	Angiotensin Receptor AntagonistsIBA 01/2021 - 01/2019
2	Adenosine Triphosphatases (ATPase)IBA 01/2017 - 01/2017
2	Caspase 3 (Caspase-3)IBA 01/2016 - 11/2011
2	pyrazolanthroneIBA 01/2016 - 01/2013
2	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2014 - 01/2013
1	MicroRNAs (MicroRNA)IBA 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	tissue-factor-pathway inhibitor 2 (PP5)IBA 01/2023
1	CreatinineIBA 01/2023
1	Sunscreening Agents (Sunscreens)IBA 01/2023
1	Serum AlbuminIBA 01/2023
1	Estrogens (Estrogen)FDA Link 01/2022
1	CalciumIBA 01/2022
1	Troponin IIBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	AngiotensinsIBA 10/2021
1	AldosteroneIBA 10/2021
1	ReninIBA 10/2021
1	CalpainIBA 01/2021
1	Mineralocorticoid Receptor AntagonistsIBA 01/2021
1	phytobacteriomycin (PBM)IBA 01/2021
1	TicagrelorIBA 11/2020
1	Clopidogrel (Plavix)FDA Link 11/2020
1	Indoleacetic Acids (Auxin)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Abscisic AcidIBA 01/2020
1	Carrier Proteins (Binding Protein)IBA 01/2020
1	ethyleneIBA 01/2020
1	LipidsIBA 03/2019
1	Enalapril FDA LinkGeneric 01/2019
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2019
1	Lysine (L-Lysine)FDA Link 01/2018
1	p38 Mitogen-Activated Protein KinasesIBA 01/2017
1	JNK Mitogen-Activated Protein KinasesIBA 01/2016
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 01/2016
1	Sodium-Calcium ExchangerIBA 01/2016
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2016
1	Angiotensin IIIBA 01/2015
1	Phosphotransferases (Kinase)IBA 01/2015
1	benzimidazoleIBA 01/2015
1	LipopolysaccharidesIBA 01/2014
1	NF-kappa B (NF-kB)IBA 01/2014

Therapy/Procedure

5	Percutaneous Coronary Intervention 11/2023 - 12/2012
2	Therapeutics 01/2022 - 01/2014
1	Length of Stay 01/2023
1	Ovariectomy (Oophorectomy) 01/2022
1	Ischemic Postconditioning 01/2022
1	Low-Level Light Therapy (LLLT) 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 03/2019
1	Thrombolytic Therapy 03/2019